A global reference tool to fight Alzheimer’s

[ad_1] It affects more than 40 million people worldwide. Early diagnosis is essential. Edmond Van Eeckhout Alzheimer’s patient carer Memory loss, language and behavioral disorders – the symptoms of Alzheimer’s…

FDA Commissioner Denies Wrongdoing in Approval Process for Biogen Alzheimer’s Drug Aduhelm

[ad_1] Robert Califf acknowledged the agency made mistakes when it failed to properly document interactions with the company. [ad_2] Source link

New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients

[ad_1] Health Medicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy [ad_2] Source link

New Alzheimer’s Drug Approved by FDA, Promises to Slow Disease

[ad_1] Health Eisai and Biogen’s Leqembi is the first drug to show that reducing a protein linked to Alzheimer’s helped patients [ad_2] Source link

How to Make Education an Investment After College

[ad_1] Markets Personal Finance Dedicating resources to learning practical and purposeful new skills can help ward off dementia and advance your career [ad_2] Source link